Get startedLog in
    Picture of Edwards Lifesciences logo

    EW — Edwards Lifesciences Cashflow Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Edwards Lifesciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    2025
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:10-K10-K10-K10-K10-K
    Standards:
    USG
    USG
    USG
    USG
    USG
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line1,5031,5221,3994,1701,069
    Depreciation
    Deferred Taxes
    Non-Cash Items-9.7233150-3,200332
    Unusual Items
    Purchased R&D
    Other Non-Cash Items
    Changes in Working Capital145-421-526-259155
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Accrued Expenses
    Change in Payable / Accrued Expenses
    Change in Taxes Payable
    Net Change in Other Assets & Liabilities
    Cash from Operating Activities1,7321,2188965421,595
    Capital Expenditures-330-265-266-282-260
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-1,3935174402,595-453
    Acquisition of Business
    Sale of Business
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-1,7232521742,313-713
    Financing Cash Flow Items-0.3-3.6-1-3.1-238
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-356-1,585-711-983-957
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-333-94.83751,911-119